Discover Tenders by Parts Seats Sector

Find the most relevant tenders for Parts Seats. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Parts Seats tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Parts Seats tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Fluticasone And Azelastine R01Ad28 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4642060

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Medicines With The Active Ingredient Combination Oxycodone And Naloxone Atc N02Aa55

Deadline: 28 Feb 2026

Germany

Ref. No.: 4641976

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tolvaptan C03Xa01 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4641684

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Medicines With The Active Ingredient Aclidinium Bromide Atc R03Bb05

Deadline: 28 Feb 2026

Germany

Ref. No.: 4641405

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Pimecrolimus D11Ah02 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4640967

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tolvaptan G04Bx21 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4640900

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Iron Ii Sulfate B03Aa07 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4640423

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Fingolimod L04Ae01 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4640403

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Rv To Provide Prevention Measures In Accordance With Sections 20 Ff Sbg V Oh Procedure

Deadline: 30 Nov 2027

Germany

Ref. No.: 4639286

EMD:Ref Document

Bid Value: Ref Document

764 Days Left

Medicines With The Active Ingredient Tacrolimus Atc L04Ad02

Deadline: 28 Feb 2026

Germany

Ref. No.: 4638957

EMD:Ref Document

Bid Value: Ref Document

124 Days Left

Conclusion Of A Non Exclusive Framework Contract For Test Engineering Services In The Open House Procedure Of The Westphalia Branch

Deadline: 31 Jan 2028

Germany

Ref. No.: 4572925

EMD:Ref Document

Bid Value: Ref Document

826 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Trientine Atc A16Ax12 For The Period May 1 2024 April 30 2026

Deadline: 05 Mar 2026

Germany

Ref. No.: 4539705

EMD:Ref Document

Bid Value: Ref Document

129 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Sofosbuvir And Velpatasvir Atc J05Ap55 For The Period May 1 2024 April 30 2026

Deadline: 05 Mar 2026

Germany

Ref. No.: 4539071

EMD:Ref Document

Bid Value: Ref Document

129 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Molsidomine Atc C01Dx12 For The Period May 1 2024 April 30 2026

Deadline: 05 Mar 2026

Germany

Ref. No.: 4538062

EMD:Ref Document

Bid Value: Ref Document

129 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Megestrol Atc L02Ab01 For The Period May 1 2024 April 30 2026

Deadline: 05 Mar 2026

Germany

Ref. No.: 4534822

EMD:Ref Document

Bid Value: Ref Document

129 Days Left

Showing 59371 to 59385 of 59500 results

‹
1
2
...
3956
3957
3958
3959
3960
3961
3962
...
3966
3967
›

Discover Tenders by Parts Seats Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Parts Seats Sector

Filter Your Search

FREE Trial plan for all new users!